Manu Ohri Email

Chief Financial Officer . GT Biopharma

Current Roles

Employees:
9
Revenue:
$697.5k
About
Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia and multiple solid tumors by leveraging our proprietary NK cell engager (TriKE™) platform technology. (NASDAQ: GTBP)
GT Biopharma Address
8000 Marina Blvd
Beverly Hills, CA
United States
GT Biopharma Email